Literature DB >> 9509898

Neural actions of immunophilin ligands.

S H Snyder1, D M Sabatini, M M Lai, J P Steiner, G S Hamilton, P D Suzdak.   

Abstract

Immunophilins, protein receptors for immunosuppressant drugs such as cyclosporin A and FK506, are enriched far more in the brain than in the immune system. Drug-immunophilin complexes bind to calcineurin, inhibiting its phosphatase activity and leading to immunosuppressant effects. The immunophilin FKBP-12 (FK506 binding protein, 12 kDa) forms a complex with the ryanodine and inositol (1,4,5) trisphosphate (IP3) receptors to regulate their physiological release of intracellular Ca2+. Here, Solomon Snyder and colleagues describe how non-immunosuppressant as well as immunosuppressant immunophilin ligands are neurotrophic for numerous classes of damaged neurones, both in culture systems and intact animals. Their ability to stimulate functional regrowth of damaged sciatic, cortical cholinergic, dopamine and 5-HT neurones may have therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9509898     DOI: 10.1016/s0165-6147(97)01146-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  29 in total

1.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia.

Authors:  Tsuyoshi Miyakawa; Lorene M Leiter; David J Gerber; Raul R Gainetdinov; Tatyana D Sotnikova; Hongkui Zeng; Marc G Caron; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

2.  Design and structure-based study of new potential FKBP12 inhibitors.

Authors:  Fei Sun; Pengyun Li; Yi Ding; Liwei Wang; Mark Bartlam; Cuilin Shu; Beifen Shen; Hualiang Jiang; Song Li; Zihe Rao
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

Review 3.  Cyclophilins and their possible role in the stress response.

Authors:  L Andreeva; R Heads; C J Green
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

4.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

5.  Deletion of the C-terminal 138 amino acids of the wheat FKBP73 abrogates calmodulin binding, dimerization and male fertility in transgenic rice.

Authors:  Isaac Kurek; Rivka Dulberger; Abdussalam Azem; Batsheva Ben Tzvi; Duraialagaraja Sudhakar; Paul Christou; Adina Breiman
Journal:  Plant Mol Biol       Date:  2002-03       Impact factor: 4.076

6.  Tacrolimus-induced neurotoxicity and nephrotoxicity is ameliorated by administration in the dark phase in rats.

Authors:  Atsushi Yamauchi; Ryozo Oishi; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

7.  Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.

Authors:  Cristina Malagelada; Zong Hao Jin; Vernice Jackson-Lewis; Serge Przedborski; Lloyd A Greene
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

8.  Early treatment with cyclosporin A ameliorates the reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia.

Authors:  Y Kondo; M Asanuma; E Iwata; F Kondo; I Miyazaki; N Ogawa
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

9.  In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6.

Authors:  Christopher H George; Rina Sorathia; Benedicte M A Bertrand; F Anthony Lai
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

10.  Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells.

Authors:  Ken-ichi Tanaka; Masato Asanuma; Norio Ogawa
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.